Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001214659-25-007875·TANG CAPITAL MANAGEMENT LLC
Schedule 13G ownership disclosure
ITEOS THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 46565G104
Event date: 2025-05-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLC
Shares: 3,826,692.00 · Class: 9.99%
- KEVIN TANG
Shares: 3,826,692.00 · Class: 9.99%
- TANG CAPITAL PARTNERS, LP
Shares: 2,618,219.00 · Class: 6.84%
- TANG CAPITAL PARTNERS INTERNATIONAL, LP
Shares: 1,208,473.00 · Class: 3.15%
- TANG CAPITAL PARTNERS III, INC
Shares: 0.00 · Class: 0.0%
- TANG CAPITAL PARTNERS IV, INC
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-007875
- Form type
- SCHEDULE 13G
- Filer
- TANG CAPITAL MANAGEMENT LLC
- CIK
- CIK 1232621
- Filed
- May 15, 2025
- Reporting period
- May 13, 2025
- Description
- Schedule 13G beneficial ownership